Green P H, Riley J W
Aust N Z J Med. 1981 Feb;11(1):84-90. doi: 10.1111/j.1445-5994.1981.tb03746.x.
Lipid absorption is a complex process which involves coordinated gastric, intestinal, biliary and pancreatic function. Emulsification of dietary lipid occurs in the stomach and upper intestine where a series of enzymic events also occur. Phospholipids are digested by phospholipases. Colipase anchors lipase to the emulsion surface overcoming the interfering effect of bile salts. The products of lipolysis, monoglycerides and fatty acids, are removed from the emulsion surface by bile salts in the form of mixed micelles which transport lipid digestive products across the unstirred water layer to the epithelial cell. Within the intestinal epithelial cell a series of synthetic events occur resulting in the formation of chylomicrons and very low density lipoprotein (VLDL). Chylomicrons consists of an oily core of triglyceride surrounded by a membrane of phospholipids, free cholesterol and apoproteins which maintain the solubility of the particle in plasma. Chylomicrons from both experimental animals and man have specific apoproteins associated with them. These proteins include apoA-I, the major protein of plasma high density lipoproteins. During chylomicron metabolism, apoA-I and phospholipid from the chylomicron surface contribute to plasma high density lipoproteins. Other chylomicron apoproteins include apoB and apoA-IV, which are synthesized in the intestine, and apoC and apoE which are absorbed onto the chylomicron surface from other lipoproteins. The intestines also synthesizes, very low density sized particles (VLDL) while fasting and during lipid absorption. There is evidence that the intestine also synthesizes high density lipoproteins. The intestine has recently been recognized as a major site of synthesis of plasma lipoproteins and apoproteins, especially apoA-I for plasma high density lipoproteins.
脂质吸收是一个复杂的过程,涉及胃、肠、胆汁和胰腺功能的协同作用。膳食脂质的乳化发生在胃和上段小肠,同时也会发生一系列酶促反应。磷脂被磷脂酶消化。辅脂酶将脂肪酶锚定在乳剂表面,克服了胆盐的干扰作用。脂肪分解产物甘油单酯和脂肪酸以混合微胶粒的形式被胆盐从乳剂表面清除,混合微胶粒将脂质消化产物穿过未搅动水层转运到上皮细胞。在肠上皮细胞内会发生一系列合成反应,导致乳糜微粒和极低密度脂蛋白(VLDL)的形成。乳糜微粒由甘油三酯的油性核心组成,周围是磷脂、游离胆固醇和载脂蛋白膜,这些成分维持了微粒在血浆中的溶解度。实验动物和人类的乳糜微粒都有与之相关的特定载脂蛋白。这些蛋白质包括载脂蛋白A-I,它是血浆高密度脂蛋白的主要蛋白质。在乳糜微粒代谢过程中,乳糜微粒表面的载脂蛋白A-I和磷脂会形成血浆高密度脂蛋白。其他乳糜微粒载脂蛋白包括在肠道合成的载脂蛋白B和载脂蛋白A-IV,以及从其他脂蛋白吸收到乳糜微粒表面的载脂蛋白C和载脂蛋白E。在禁食和脂质吸收期间,肠道也会合成极低密度大小的颗粒(VLDL)。有证据表明肠道也会合成高密度脂蛋白。最近,肠道被认为是血浆脂蛋白和载脂蛋白合成的主要部位,尤其是血浆高密度脂蛋白的载脂蛋白A-I。